# Eurofins BioPharma Product Testing Columbia, LLC – FDA Inspection, Jan 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/eurofins-biopharma-product-testing-columbia-llc/eba63794-537e-48f1-a247-1601e534152e
Source feed: FDA_Inspections

> FDA inspection 1161343 of Eurofins BioPharma Product Testing Columbia, LLC, January 14, 2022. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1161343
- Company Name: Eurofins BioPharma Product Testing Columbia, LLC
- Inspection Date: 2022-01-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1258161 - 2024-12-04
- FDA Inspection 1065874 - 2018-08-15
- FDA Inspection 999122 - 2017-01-26
- FDA Inspection 917473 - 2015-03-06
- FDA Inspection 791170 - 2012-07-18

Company: https://www.keypedia.com/companies/eurofins-biopharma-product-testing-columbia-llc/b616a9a6-094c-4f02-80ba-59880916eaf2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c